Evidence map›Paper›PMID 39473399›Full record

ArticleJournal of biomedical materials research. Part A2025

In Vivo Assessment of an Antioxidant Hydrogel Vitreous Substitute.

Megan M Allyn, Annie K Ryan, Grace Rivera, Esther Mamo, Joshua Bopp, Sebastian Martinez Hernandez, Julie Racine, Eric J Miller, Heather L Chandler, Katelyn E Swindle-Reilly

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Replace the vitreous permanently.Nature reviews. Materials · 2026
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Megan M AllynWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio, USA.
Annie K RyanDepartment of Biomedical Engineering, The Ohio State University, Columbus, Ohio, USA.
Grace RiveraCollege of Optometry, The Ohio State University, Columbus, Ohio, USA.
Esther MamoDepartment of Veterinary Clinical Science, The Ohio State University, Columbus, Ohio, USA.
Joshua BoppCenter for Life Sciences Education, The Ohio State University, Columbus, Ohio, USA.
Sebastian Martinez HernandezDepartment of Biomedical Engineering, The Ohio State University, Columbus, Ohio, USA.
Julie RacineDepartment of Ophthalmology, Nationwide Children's Hospital, Columbus, Ohio, USA.
Eric J MillerDepartment of Veterinary Clinical Science, The Ohio State University, Columbus, Ohio, USA.
Heather L ChandlerCollege of Optometry, The Ohio State University, Columbus, Ohio, USA.
Katelyn E Swindle-ReillyWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0003-1739-0263

Funding

The Ohio State University Vision Sciences Research Core Program (OSU-VSRCP)P30EY032857 · NEI · OHIO STATE UNIVERSITY · PI Sayoko E Moroi · 2022 to 2026
$3.6M
Institute for Materials Research, Ohio State UniversityNational Science FoundationNEI NIH HHS P30 EY032857NIH HHSOhio State UniversityPrevent Blindness Ohio
6 · The paper itself

Abstract

The vitreous humor undergoes liquefaction with age, resulting in complications that may require a vitrectomy, or surgical removal of the vitreous from the eye. Silicone oil, a common vitreous substitute, lacks properties similar to the natural vitreous. In particular, it lacks antioxidants that may be necessary to reduce oxidative stress in the eye. The purpose of this study was to evaluate antioxidant-loaded hydrogel vitreous substitutes in a pilot in vivo study. Ascorbic acid and glutathione were loaded into synthesized PEGDA hydrogels. Following vitrectomy, experimental antioxidant hydrogels or silicone oil were injected into one eye of rabbits, while the other eye served as untreated or sham control. Ophthalmic assessments, including electroretinography, were performed. Levels of glutathione and ascorbic acid were higher in the eyes treated with the antioxidant-loaded hydrogel vitreous substitute, although this was not found to be significant after 28 days. There were no statistically significant differences between groups with respect to clinical examination, and ocular health scores, electroretinograms, and histology were normal. These results indicate minimal concerns for the hydrogel formulation or high levels of antioxidants. Future research will assess the capability of vitreous substitutes to prolong antioxidant release, with the goal of minimizing cataract after vitrectomy.

Indexed as

AntioxidantsElectroretinographyVitreous BodyAnimalsAscorbic AcidGlutathioneHydrogelsRabbitsVitrectomyAntioxidantsAscorbic AcidGlutathioneHydrogelsantioxidantascorbic acidglutathionehydrogelvitreous

Identifiers

PMID39473399
PMCPMC12880220

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.